利羣股份(601366.SH)衝高回落漲近5% 2019年淨利潤預增35%-50%
格隆匯12月5日丨昨晚發盈喜的利羣股份(601366.SH)早盤一度漲9.28%,目前出現回落走勢,漲幅收窄至4.82%,報5.65元,暫成交6812萬元,最新總市值48.62億元。公司昨晚公告,2019年歸屬於上市公司股東的淨利潤預計約為2.72億萬元到3億元,同比增加約7000萬元到1億元,同比增長約35%到50%。扣非淨利潤同比增長約22%到38%。公告稱,一方面隨着公司2018年併購的樂天華東區門店(已更名為“利羣時代”)開業並逐步運營,利羣時代銷售收入穩步增長,虧損逐步收窄;另一方面公司原有區域門店及批發公司銷售規模和業績持續增長,帶動公司整體業績增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.